Revolutionize the Development & Delivery of Neurological Gene Therapies
Returning this year as a digital meeting with an agenda designed with the field’s thought-leaders including Pfizer, Biogen, Voyager and Novartis, the 2nd Annual Gene Therapy for Neurological Disorders is the industry’s only meeting dedicated to solving your translational drug development challenges, enabling you to accelerate the development of your neurological gene therapy candidate.
Don't get left behind. Attend this meeting to transform gene therapy delivery to the CNS, optimize translational modelling approaches and discover targeted, efficacious and safe vectors to revolutionize the treatment of neurological disorders.
Access the official agenda for more information.
Attendees of other Gene Therapy Events Series digital meetings have said:
"It was very informative and worked exceptionally well as a remote meeting."
"Exciting new way of participating in scientific conference and discussion."